DYAI
Dyadic International, Inc.
There isn't enough reported data to score DYAI yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
DYAI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
DYAI's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
DYAI PE Valuation
DYAI has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
DYAI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect DYAI's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
DYAI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.21 | -$0.02 |
| Q1 2026 | -$0.21 | -$0.01 |
| Q4 2025 | -$0.23 | -$0.03 |
| Q3 2025 | -$0.24 | -$0.02 |
| Q2 2025 | -$0.19 | +$0.08 |
| Q1 2025 | -$0.20 | +$0.07 |
| Q4 2024 | -$0.20 | +$0.03 |
| Q3 2024 | -$0.22 | +$0.01 |
DYAI is still losing money, but far less than before: $0.21 per share over the past year, against $0.47 at its worst in late 2021.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over DYAI on earnings quality, reporting a profit while its opponent remains loss making.
DYAI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $961.1K | -0.6% |
| Q1 2026 | $1.1M | +182% |
| Q4 2025 | $565.5K | -31% |
| Q3 2025 | $1.2M | -41% |
| Q2 2025 | $966.6K | +150% |
| Q1 2025 | $393.6K | +18% |
| Q4 2024 | $817.4K | +19% |
| Q3 2024 | $2M | +393% |
DYAI's revenue has slid since its 2024 peak: $961,138 last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -214% | -35 points |
| Q1 2026 | -171% | +338 points |
| Q4 2025 | -272% | -84 points |
| Q3 2025 | -165% | -155 points |
| Q2 2025 | -179% | +350 points |
| Q1 2025 | -509% | +126 points |
| Q4 2024 | -187% | +129 points |
| Q3 2024 | -10% | +423 points |
DYAI's operating margin was −214% last quarter, down 35 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over DYAI on profitability, with a higher operating margin.
DYAI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8M | -$1.7M |
| Q1 2026 | -$2M | -$13.6K |
| Q4 2025 | -$1.8M | -$1.1M |
| Q3 2025 | -$1.9M | -$1.7M |
| Q2 2025 | -$130K | +$1.8M |
| Q1 2025 | -$1.9M | -$836.8K |
| Q4 2024 | -$696.4K | +$227K |
| Q3 2024 | -$201.1K | +$1.8M |
DYAI has burned cash in almost every quarter: −$7M over the past year, against −$3M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over DYAI on cash generation, producing positive trailing cash flow while its opponent burns cash.
DYAI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +40.7K shares |
| 1 year | +21% | +6.3M shares |
| 3 years | +26% | +7.6M shares |
| 5 years | +32% | +8.8M shares |
| Available history | +34% | +9.3M shares |
DYAI has 36M diluted shares, up 21% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
| Q3 2019 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over DYAI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
DYAI Net Leverage
DYAI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
DYAI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.7 | Neutral |
| Stochastic | 2.7 | Oversold |
DYAI's weekly RSI is 32 (neutral) and its Stochastic is 3 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
DYAI PE vs Healthcare Sector
DYAI has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
DYAI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.40 | 13% below |
| 20 week MA | $0.66 | 47% below |
| 50 week MA | $0.77 | 55% below |
| 100 week MA | $0.98 | 64% below |
| 200 week MA | $1.30 | 73% below |
DYAI is in a downtrend: it's below all five of its weekly moving averages, and 73% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over DYAI on trend strength, trading above more of its moving averages.
DYAI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.28 | $5.57 | +5.5% |
| 2021 | $5.57 | $4.11 | -26% |
| 2022 | $4.11 | $1.37 | -67% |
| 2023 | $1.37 | $1.61 | +18% |
| 2024 | $1.61 | $1.96 | +22% |
| 2025 | $1.96 | $0.95 | -52% |
| 2026 YTD | $0.95 | $0.35 | -63% |
DYAI has finished lower in three of the last six years. It's down 63% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over DYAI on returns for 2026, with the stronger performance.